Literature DB >> 15306253

Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans.

Daniel Umbricht1, Dimitri Vyssotky, Alexander Latanov, Roger Nitsch, Riccardo Brambilla, Patrizia D'Adamo, Hans-Peter Lipp.   

Abstract

Midlatency event-related potentials (ERPs) reflect early stages in processing of modality specific information. In humans, the auditory midlatency ERPs most investigated are the P1, N1 and P2. Abnormalities of these ERPs in neuropsychiatric disorders such as schizophrenia point to deficits in information processing at early stages. Investigations of corresponding ERPs in mice might thus permit to elucidate the molecular biology of such abnormalities. We conducted studies in mice and humans in order to establish the correspondence of midlatency ERPs in mice to the human P1, N1 and P2. We investigated their so-called recovery function-i.e. their systematic amplitude changes as a function of varying stimulus onset asynchrony (SOA). Furthermore, we explored effects of specific genetic alterations (ERK1 gene deletion Gdi1 gene deletion) on this measure. In mice, P1-like activity showed a significant recovery not present in human data. In contrast, N1-like and P2-like activity in mice demonstrated similar recovery functions as the corresponding ERPs in human subjects and could be best fitted by the same function. In addition, ERK1 gene knockout mice showed a significantly different N1 recovery function compared to wild-type mice, possibly related to enhanced memory functions in these mice. Our results indicate that midlatency ERPs in mice share some, but not all, characteristics with the human P1, N1 and P2. As in humans, N1 recovery may provide an assessment of auditory sensory memory function. Investigations of these ERPs in mice may thus permit to elucidate the abnormalities underlying deficient generation of these ERPs in neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306253     DOI: 10.1016/j.brainres.2004.05.097

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

Review 1.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

2.  NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders.

Authors:  John A Saunders; Michael J Gandal; Timothy P Roberts; Steve J Siegel
Journal:  Behav Brain Res       Date:  2012-07-05       Impact factor: 3.332

3.  Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients.

Authors:  C R Maxwell; Y Liang; M P Kelly; S J Kanes; T Abel; S J Siegel
Journal:  Neuroscience       Date:  2006-06-05       Impact factor: 3.590

4.  In vitro and in vivo demonstration of risperidone implants in mice.

Authors:  C Rabin; Y Liang; R S Ehrlichman; A Budhian; K L Metzger; C Majewski-Tiedeken; K I Winey; S J Siegel
Journal:  Schizophr Res       Date:  2007-08-31       Impact factor: 4.939

Review 5.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 6.  Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Authors:  D Sinclair; B Oranje; K A Razak; S J Siegel; S Schmid
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

7.  NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.

Authors:  John A Saunders; Michael J Gandal; Steve J Siegel
Journal:  Neurobiol Dis       Date:  2012-01-09       Impact factor: 5.996

8.  MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.

Authors:  Wenlin Liao; Michael J Gandal; Richard S Ehrlichman; Steven J Siegel; Greg C Carlson
Journal:  Neurobiol Dis       Date:  2012-01-09       Impact factor: 5.996

9.  Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.

Authors:  Noam D Rudnick; Andrew A Strasser; Jennifer M Phillips; Christopher Jepson; Freda Patterson; Joseph M Frey; Bruce I Turetsky; Caryn Lerman; Steven J Siegel
Journal:  Nicotine Tob Res       Date:  2010-04-15       Impact factor: 4.244

10.  Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes.

Authors:  John A Saunders; Valerie M Tatard-Leitman; Jimmy Suh; Eddie N Billingslea; Timothy P Roberts; Steven J Siegel
Journal:  Autism Res       Date:  2013-02-25       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.